Trials / Sponsors / Arrys Therapeutics
Arrys Therapeutics
Industry · 2 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Terminated | Grapiprant (ARY-007) and Pembrolizumab in Patients With Advanced or Metastatic Post-PD-1/L1 NSCLC Adenocarcino Non-small Cell Lung Cancer Adenocarcinoma | Phase 1 / Phase 2 | 2019-01-08 |
| Completed | Grapiprant and Pembrolizumab in Patients With Advanced or Progressive MSS Colorectal Cancer Microsatellite Stable Colorectal Cancer | Phase 1 | 2018-09-20 |